                         SEQUENCE LISTING

<110>  Origin IP Limited
 
<120>  PEPTIDE SYNTHESIS

<130>  P197914.WO.01

<150>  GB1817932.5
<151>  2018-11-02

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesised peptide

<400>  1

Val Pro Asp Asn Leu Gln Gln Ser Leu Ser Asp Glu Ala Gln Arg 
1               5                   10                  15  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesised peptide

<400>  2

Val Met Asp Ser Ser Tyr Leu Ser Arg 
1               5                   


<210>  3
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthesised peptide

<400>  3

Trp Arg Trp Leu Glu His Asn Val Val Glu Gly Asn Ala Val Asn Leu 
1               5                   10                  15      


Met Phe Ser Lys 
            20  


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial sequence

<400>  4

Met Arg Phe Ala 
1               


<210>  5
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial sequence

<400>  5

Thr Gly Ala Ser Leu Asn Ser Arg 
1               5               


<210>  6
<211>  110
<212>  PRT
<213>  Homo sapiens

<400>  6

Met Ala Leu Trp Met Arg Leu Leu Pro Leu Leu Ala Leu Leu Ala Leu 
1               5                   10                  15      


Trp Gly Pro Asp Pro Ala Ala Ala Phe Val Asn Gln His Leu Cys Gly 
            20                  25                  30          


Ser His Leu Val Glu Ala Leu Tyr Leu Val Cys Gly Glu Arg Gly Phe 
        35                  40                  45              


Phe Tyr Thr Pro Lys Thr Arg Arg Glu Ala Glu Asp Leu Gln Val Gly 
    50                  55                  60                  


Gln Val Glu Leu Gly Gly Gly Pro Gly Ala Gly Ser Leu Gln Pro Leu 
65                  70                  75                  80  


Ala Leu Glu Gly Ser Leu Gln Lys Arg Gly Ile Val Glu Gln Cys Cys 
                85                  90                  95      


Thr Ser Ile Cys Ser Leu Tyr Gln Leu Glu Asn Tyr Cys Asn 
            100                 105                 110 


<210>  7
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  VR15

<400>  7

Arg Gln Ala Glu Asp Ser Leu Ser Gln Gln Leu Asn Asp Pro Val 
1               5                   10                  15  


